02Dec 2023
Lupin Launches Contraceptive Tablet Turqoz® in the U.S. Following FDA Approval

Lupin Launches Contraceptive Tablet Turqoz® in the U.S. Following FDA Approval

Mumbai-based pharmaceutical giant Lupin Limited has unveiled Turqoz® (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg, following U.S. Food and Drug Administration (FDA) approval. This generic equivalent of Lo/Ovral-28 serves as a contraceptive to prevent pregnancy. With an estimated annual sales value of USD 33 million in the U.S., Lupin stands as the third-largest pharmaceutical company in the country by prescriptions, emphasizing its strong presence in cardiovascular, anti-diabetic, and respiratory segments.

  • #gynaecology - ivf

Like

Save

Share